V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012078 | 330010163 | 1.78 | 85.7 | Curative (C) | 2015-04-13 | 2015-06-13 | CISPLATIN + RT | N | N | 330000684 | CISPLATIN + RT |
| 330012079 | 330003094 | 1.92 | 84.9 | Adjuvant (A) | 2015-03-23 | 2015-04-18 | Cisplatin + Radiotherapy | 02 | Y | 330000793 | CISPLATIN + RT |
| 330012080 | 330003108 | 1.61 | null | Curative (C) | 2013-01-04 | 2013-10-15 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330000894 | NOT MATCHED |
| 330012081 | 330003131 | 1.63 | null | Adjuvant (A) | 2015-03-02 | 2015-03-19 | CISPLATIN + RT | 02 | Y | 330001087 | CISPLATIN + RT |
| 330012082 | 330003167 | 1.69 | null | Curative (C) | 2018-08-16 | 2019-05-20 | CISPLATIN + RT | N | null | 330001376 | CISPLATIN + RT |
| 330012083 | 330003178 | 1.88 | 13.8 | Curative (C) | 2015-03-27 | 2016-09-07 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330001442 | NOT MATCHED |
| 330012084 | 330003179 | 1.75 | 83 | Curative (C) | 2015-09-27 | 2015-10-07 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330001484 | CISPLATIN + RT |
| 330012085 | 330003189 | null | 136.5 | 1 | 2014-11-08 | 2014-11-09 | Cisplatin + Radiotherapy | 02 | Y | 330001612 | CISPLATIN + RT |
| 330012086 | 330003201 | 1.76 | 56.8 | Not known (9) | 2015-11-14 | 2016-05-14 | CISPLATIN + RT | 2 | Y | 330001765 | CISPLATIN + RT |
| 330012087 | 330003222 | null | 85.8 | Neo-adjuvant (N) | 2017-08-03 | 2017-08-04 | NB HRNBL-1 Isotretinoin | N | null | 330001925 | NOT MATCHED |
| 330012088 | 330003232 | 0 | 19.2 | Palliative (P) | 2016-10-04 | 2016-10-04 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330001982 | NOT MATCHED |
| 330012089 | 330003238 | 0.93 | 59 | Curative (C) | 2014-01-20 | 2014-01-23 | NB HRNBL-1 COJEC Ind COURSE C | null | null | 330002000 | NOT MATCHED |
| 330012090 | 330003245 | null | 43 | Curative (C) | 2017-05-26 | 2017-07-28 | Cisplatin + Radiotherapy | N | Y | 330002044 | CISPLATIN + RT |
| 330012091 | 330007727 | 0 | 55.8 | Adjuvant (A) | 2014-07-01 | 2014-07-15 | CISPLATIN + RT | null | Y | 330002063 | CISPLATIN + RT |
| 330012092 | 330003259 | 1.86 | 86 | Curative (C) | 2013-11-22 | 2013-11-22 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 330002078 | CISPLATIN + RT |
| 330012093 | 330007738 | 1.57 | 42.1 | Curative (C) | 2015-08-29 | 2016-02-29 | NB Rel CCLG guidelines Cyclo-Topotecan | 02 | N | 330002189 | NOT MATCHED |
| 330012094 | 330007753 | null | 79.7 | Curative (C) | 2014-07-12 | 2014-07-19 | Cisplatin + Radiotherapy | 02 | null | 330002377 | CISPLATIN + RT |
| 330012095 | 330003300 | 1.68 | 123.6 | Adjuvant (A) | 2013-08-10 | 2014-02-17 | CISPLATIN + RT | 02 | Y | 330002460 | CISPLATIN + RT |
| 330012096 | 330003314 | 1.62 | 77.7 | Curative (C) | 2013-01-31 | 2015-10-25 | Cisplatin + Radiotherapy | N | Y | 330002530 | CISPLATIN + RT |
| 330012097 | 330010235 | 1 | 10.8 | Curative (C) | 2015-04-05 | 2016-04-14 | NB BEACON Temozolomide Topotecan | 2 | N | 330002705 | NOT MATCHED |
| 330012099 | 330003337 | 1.61 | 85.9 | Curative (C) | 2015-12-10 | 2016-01-07 | CISPLATIN + RT | 02 | Y | 330002743 | CISPLATIN + RT |
| 330012100 | 330003366 | 1.51 | 12.1 | Disease modification (D) | 2014-10-14 | 2015-04-12 | NB HRNBL-1 COJEC Ind COURSE C | Y | N | 330002884 | NOT MATCHED |
| 330012101 | 330003383 | 0 | 52.8 | Curative (C) | 2016-03-05 | 2016-11-12 | LCHIV Cont A | 2 | Y | 330002981 | NOT MATCHED |
| 330012102 | 330003401 | 1.72 | 77 | Adjuvant (A) | 2017-01-01 | 2017-09-03 | Cisplatin 100 + RT(H&N) 1 day | null | null | 330003028 | CISPLATIN + RT |
| 330012103 | 330003403 | 1.7 | 55.1 | Curative (C) | 2016-03-09 | 2016-03-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330003049 | CISPLATIN + RT |
| 330012104 | 330003409 | null | null | Curative (C) | 2015-07-06 | 2015-07-08 | Cisplatin + Radiotherapy | 02 | N | 330003085 | CISPLATIN + RT |
| 330012105 | 330003420 | 1.67 | 64 | Not known (9) | 2018-01-25 | 2018-05-06 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 330003181 | CISPLATIN + RT |
| 330012106 | 330003432 | 1.79 | 62 | Curative (C) | 2016-02-14 | 2016-02-19 | Cisplatin + Radiotherapy | 02 | Y | 330003276 | CISPLATIN + RT |
| 330012107 | 330003439 | 0 | 40.3 | null | null | 2014-06-30 | CNS LGG 2004 03 cons vinc +cyclo | N | N | 330003325 | NOT MATCHED |
| 330012108 | 330003445 | 0 | 12.1 | Palliative (P) | 2016-10-28 | 2016-11-18 | BMT | Y | N | 330003339 | NOT MATCHED |
| 330012109 | 330003448 | 0 | 13.8 | Curative (C) | 2015-05-24 | 2015-05-30 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330003346 | NOT MATCHED |
| 330012110 | 330007846 | null | 69 | Curative (C) | 2015-02-24 | 2015-02-24 | EW EuroEwing 2012 Arm A/B BuMEL | N | N | 330003386 | NOT MATCHED |
| 330012111 | 330003463 | 0.86 | 11.1 | Adjuvant (A) | 2016-07-30 | 2016-08-02 | ETOPOSIDE + THIOTEPA | 02 | Y | 330003394 | NOT MATCHED |
| 330012112 | 330003466 | 0 | 25.7 | Adjuvant (A) | 2016-08-04 | 2017-01-25 | NB HRNBL-1 TVD | null | null | 330003396 | NOT MATCHED |
| 330012113 | 330003468 | null | 96.6 | Radical (R) | 2017-12-01 | 2017-12-08 | Cisplatin + Radiotherapy | N | Y | 330003402 | CISPLATIN + RT |
| 330012114 | 330003472 | null | 90.5 | Curative (C) | 2014-07-06 | 2014-07-31 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330003438 | CISPLATIN + RT |
| 330012115 | 330003482 | 1.73 | null | Curative (C) | 2014-11-19 | 2014-12-04 | Cisplatin + Radiotherapy | 2 | Y | 330003495 | CISPLATIN + RT |
| 330012116 | 330003484 | 1.57 | 9.8 | null | null | 2014-08-29 | Cisplatin + Radiotherapy | null | N | 330003503 | CISPLATIN + RT |
| 330012117 | 330003488 | 0 | 59.1 | Adjuvant (A) | 2015-08-08 | 2015-08-13 | OST Rel Ifosfamide Etoposide Mtx | N | N | 330003518 | NOT MATCHED |
| 330012118 | 330007868 | 1.76 | 86.6 | Curative (C) | 2014-03-21 | 2014-03-21 | Cisplatin + Radiotherapy | 2 | N | 330003528 | CISPLATIN + RT |
| 330012119 | 330003495 | 1.35 | 64.6 | Curative (C) | null | 2014-03-11 | NB Rel CCLG guidelines Irin & Temoz | N | null | 330003536 | NOT MATCHED |
| 330012120 | 330003499 | 1.54 | null | Adjuvant (A) | 2017-05-14 | 2017-05-14 | Cisplatin + Radiotherapy | N | N | 330003565 | CISPLATIN + RT |
| 330012121 | 330003500 | null | 12.3 | Disease modification (D) | 2017-01-22 | 2017-02-13 | EW EuroEwing 2012 Arm B VC | 02 | N | 330003568 | NOT MATCHED |
| 330012122 | 330007877 | null | 92.6 | Neo-adjuvant (N) | 2014-08-25 | 2014-08-30 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330003578 | CISPLATIN + RT |
| 330012123 | 330003518 | 1.64 | 12.1 | Curative (C) | 2015-11-12 | 2015-11-29 | NB HRNBL-1 ch14.18/CHO only (trial) | N | Y | 330003643 | NOT MATCHED |
| 330012124 | 330003520 | 0 | 13 | Palliative (P) | 2016-11-06 | 2018-04-24 | NB HRNBL-1 BUMEL MAT | N | null | 330003651 | NOT MATCHED |
| 330012125 | 330003521 | null | 68 | Neo-adjuvant (N) | 2018-05-28 | 2018-06-12 | AML Interim Guidelines | N | N | 330003656 | NOT MATCHED |
| 330012126 | 330003533 | null | 11.2 | Curative (C) | 2014-11-22 | 2014-12-12 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 330003735 | NOT MATCHED |
| 330012127 | 330003536 | 0 | 11 | Curative (C) | 2017-01-06 | 2017-06-16 | NB HRNBL-1 BUMEL MAT | N | N | 330003743 | NOT MATCHED |
| 330012129 | 330003545 | 0 | 13 | null | 2017-12-30 | 2017-12-30 | null | 02 | N | 330004796 | NOT MATCHED |